Endologix (NSDQ:ELGX) has taken out a $210.5 million convertible loan facility, according to a recently posted SEC filing.
The Irvine, Calif.-based company said that it entered into the loan facility for $210.5 and issued warrants to purchase, with three unnamed investors participating in the warrant purchase.
The first sale in the offering was noted on August 9, according to the SEC filing.
Endologix has not yet stated how it intends to use funds from the credit facility, or who the credit facility is with.
Earlier this month, Endologix said that it doesn’t expect to receive FDA premarket approval for its Nellix 3.5 endovascular sealing system until 2021.
The post Endologix takes out $210m convertible loan appeared first on MassDevice.
from MassDevice https://ift.tt/2o1lzTu
Cap comentari:
Publica un comentari a l'entrada